Cargando…

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01(B) in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

BACKGROUND: A vaccine to prevent infection and disease caused by Plasmodium vivax is needed both to reduce the morbidity caused by this parasite and as a key component in efforts to eradicate malaria worldwide. Vivax malaria protein 1 (VMP001), a novel chimeric protein that incorporates the amino- a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Jason W., Yadava, Anjali, Tosh, Donna, Sattabongkot, Jetsumon, Komisar, Jack, Ware, Lisa A., McCarthy, William F., Cowden, Jessica J., Regules, Jason, Spring, Michele D., Paolino, Kristopher, Hartzell, Joshua D., Cummings, James F., Richie, Thomas L., Lumsden, Joanne, Kamau, Edwin, Murphy, Jittawadee, Lee, Cynthia, Parekh, Falgunee, Birkett, Ashley, Cohen, Joe, Ballou, W. Ripley, Polhemus, Mark E., Vanloubbeeck, Yannick F., Vekemans, Johan, Ockenhouse, Christian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769081/ https://www.ncbi.nlm.nih.gov/pubmed/26919472 http://dx.doi.org/10.1371/journal.pntd.0004423

Ejemplares similares

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
por: Ockenhouse, Christian F., et al.
Publicado: (2015)

Measurement of parasitological data by quantitative real-time PCR from controlled human malaria infection trials at the Walter Reed Army Institute of Research
por: Kamau, Edwin, et al.
Publicado: (2014)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

Comparative evaluation of published real-time PCR assays for the detection of malaria following MIQE guidelines
por: Alemayehu, Saba, et al.
Publicado: (2013)

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
por: Nielsen, C.M., et al.
Publicado: (2018)

Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
por: Moon, James J., et al.
Publicado: (2012)

Phenotypic characterization of Plasmodium berghei responsive CD8+ T cells after immunization with live sporozoites under chloroquine cover
por: Brando, Clara, et al.
Publicado: (2014)

The challenges of Plasmodium vivax human malaria infection models for vaccine development
por: Roobsoong, Wanlapa, et al.
Publicado: (2023)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Climate Change and Malaria Transmission in Thailand
por: Prachumsri, Jetsumon Sattabongkot
Publicado: (2011)

Multiplex qPCR for Detection and Absolute Quantification of Malaria
por: Kamau, Edwin, et al.
Publicado: (2013)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
por: Waitumbi, John N., et al.
Publicado: (2009)

Correction to: Transmission risk beyond the village: entomological and human factors contributing to residual malaria transmission in an area approaching malaria elimination on the Thailand–Myanmar border
por: Edwards, Hannah M., et al.
Publicado: (2019)

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
por: Chaudhury, Sidhartha, et al.
Publicado: (2016)

Identification of Plasmodium malariae, a Human Malaria Parasite, in Imported Chimpanzees
por: Hayakawa, Toshiyuki, et al.
Publicado: (2009)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection
por: Du, Ying, et al.
Publicado: (2020)

Highly heterogeneous residual malaria risk in western Thailand
por: Nguitragool, Wang, et al.
Publicado: (2019)

Sample-ready multiplex qPCR assay for detection of malaria
por: Kamau, Edwin, et al.
Publicado: (2014)

Microgeography and molecular epidemiology of malaria at the Thailand-Myanmar border in the malaria pre-elimination phase
por: Parker, Daniel M., et al.
Publicado: (2015)

G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2021)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2023)

Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission
por: Griffin, Paul, et al.
Publicado: (2016)

Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles Antigens
por: Chaudhury, Sidhartha, et al.
Publicado: (2022)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
por: Leach, Amanda, et al.
Publicado: (2011)

Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination
por: Baum, Elisabeth, et al.
Publicado: (2016)

Post-malaria neurological syndrome: a rare neurological complication of malaria
por: Yadava, Sanjay K., et al.
Publicado: (2019)

Population genetic structure of the malaria vector Anopheles minimus in Thailand based on mitochondrial DNA markers
por: Bunmee, Kamonchanok, et al.
Publicado: (2021)

High-Throughput Antibody Profiling Identifies Targets of Protective Immunity against P. falciparum Malaria in Thailand
por: Hassan, Ifra, et al.
Publicado: (2023)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
por: Abdulla, Salim, et al.
Publicado: (2013)

344. Post Malaria Neurological Syndrome: A Rare Complication of Malaria
por: Yadava, Sanjay, et al.
Publicado: (2018)

Spatio-temporal trends of malaria incidence from 2011 to 2017 and environmental predictors of malaria transmission in Myanmar
por: Zhao, Yan, et al.
Publicado: (2023)

Projecting malaria elimination in Thailand using Bayesian hierarchical spatiotemporal models
por: Rotejanaprasert, Chawarat, et al.
Publicado: (2023)

Resurgent and delayed malaria
por: Greenwood, Brian, et al.
Publicado: (2022)

Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China
por: Jangpatarapongsa, Kulachart, et al.
Publicado: (2012)

Plasmodium malariae and Plasmodium ovale infections in the China–Myanmar border area
por: Li, Peipei, et al.
Publicado: (2016)

Prevalence of asymptomatic Plasmodium infections with sub-microscopic parasite densities in the northwestern border of Thailand: a potential threat to malaria elimination
por: Sattabongkot, Jetsumon, et al.
Publicado: (2018)

Imported Plasmodium falciparum and locally transmitted Plasmodium vivax: cross-border malaria transmission scenario in northwestern Thailand
por: Sriwichai, Patchara, et al.
Publicado: (2017)

Implementation of a novel PCR based method for detecting malaria parasites from naturally infected mosquitoes in Papua New Guinea
por: Hasan, Arif U, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ap635v56j49kusj23kun1a69md